geo medical magic colour (polymacon) 38% aspheric soft contact lenses
eyesation singapore private limited - ophthalmology - for daily wear to correct visual acuity in aphakic.
geo medical mimi (polymacon) 38% aspheric soft contact lenses
eyesation singapore private limited - ophthalmology - for daily wear to correct visual acuity in aphakic.
geo medical rx-3 (polymacon) 38% aspheric soft contact lens
eyesation singapore private limited - ophthalmology - for daily wear to correct visual acuity in aphakic.
geo medical olens 1-day contact lens
emergo singapore consulting private limited - ophthalmology - soft contact lenses are for daily wear to correct visual acuity in non-aphakic persons with non-diseased eyes with myopia. the lens is available clear or tinted.
geo medical olens h40 spanish circle soft contact lenses
emergo singapore consulting private limited - ophthalmology - soft contact lenses are for daily wear to correct visual acuity in aphakic and not aphakic persons with non-diseased eyes with myopia. the lens may be worn by persons who exhibit refractive astigmatism of 0.50 diopters or less where the astigmatism does not interfere with visual acuity.
flucelvax quadrivalent (influenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated
seqirus inc. - influenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated) (unii: b8p3xn76w4) (influenza a virus a/georgia/12/2022 cvr-167 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated) - unii:n8jks3vk2a), influenza a virus a/darwin/11/2021 (h3n2) antigen (mdck cell derived, propiolactone inactivated) (unii: pv9k2r8hrm) (influenza a virus a/darwin/11/2021 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated) - unii:c6pm4nxj3 - flucelvax quadrivalent is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes a and types b contained in the vaccine. flucelvax quadrivalent is approved for use in persons 6 months of age and older. [see clinical studies (14)] do not administer flucelvax quadrivalent to anyone with a history of severe allergic reaction (e.g. anaphylaxis) to any component of the vaccine [see description (11)] . risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. data collected in a prospective pregnancy exposure registry from 665 women vaccinated with flucelvax quadrivalent showed no evidence of a vaccine-associated increase in the risk of major birth defects and miscarriages when flucelvax quadrivalent is administered during any trime
geometric shape exerciser
stay in touch solutions pty ltd -
pigeon anti-mosquito wet tissues
havenhall pty ltd - ethyl butylacetylaminopropionate - impregnated wet tissue - ethyl butylacetylaminopropionate amino acid-ester active 75.0 g/kg - household insecticide - pest control - personal use - mosquito | adult mosquitoes
georgia strain (infectous coryza inactivated vaccine)
freeze dried substance of georgia (intermediate) strian of ibd virus
pharmavac pha inj. emuls. s.c. vial
pharmagal bio spol. s.r.o. - newcastle disease virus (inactivated) ; fowl adenoviruses type 8 (inactivated) >= 24,7 elisa u; pigeon herpes virus 1 (inactivated) >= 38,1 elisa u - emulsion for injection - paramyxovirus (newcastle disease virus), inactivated; pigeon herpes virus, inactivated; poultry adenovirus type 8, inactivated - inactivated viral vaccines - pigeon